Paloma Partners’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-7,200
Closed -$1.13M 2487
2020
Q4
$1.13M Buy
+7,200
New +$925K 0.05% 537
2020
Q2
Sell
-8,010
Closed -$719K 2317
2020
Q1
$719K Sell
8,010
-17,937
-69% -$1.76M 0.07% 385
2019
Q4
$2.81M Buy
25,947
+22,850
+738% +$2.44M 0.07% 455
2019
Q3
$304K Buy
+3,097
New +$349K 0.01% 1518
2019
Q2
Sell
-28,382
Closed -$3.84M 2343
2019
Q1
$3.84M Buy
28,382
+14,712
+108% +$1.83M 0.13% 241
2018
Q4
$1.33M Buy
+13,670
New +$1.62M 0.06% 366
2018
Q3
Sell
-1,714
Closed -$215K 2089
2018
Q2
$213K Sell
1,714
-16,116
-90% -$1.88M 0.01% 1443
2018
Q1
$1.99M Buy
17,830
+13,103
+277% +$1.57M 0.07% 577
2017
Q4
$565K Sell
4,727
-16,482
-78% -$2.01M 0.02% 1298
2017
Q3
$2.98M Buy
+21,209
New +$2.88M 0.09% 501
2017
Q2
Sell
-18,264
Closed -$2.21M 2537
2017
Q1
$2.21M Buy
+18,264
New +$2.35M 0.06% 723
2016
Q4
Sell
-17,430
Closed -$2.14M 2228
2016
Q3
$2.14M Buy
17,430
+3,761
+28% +$484K 0.09% 508
2016
Q2
$1.6M Buy
13,669
+12,098
+770% +$1.72M 0.04% 857
2016
Q1
$219K Sell
1,571
-7,840
-83% -$1.15M 0.01% 1653
2015
Q4
$1.79M Buy
+9,411
New +$1.64M 0.09% 407
2015
Q3
Sell
-13,781
Closed -$2.49M 2061
2015
Q2
$2.49M Buy
13,781
+10,181
+283% +$1.76M 0.09% 368
2015
Q1
$624K Buy
3,600
+1,125
+45% +$204K 0.03% 689
2014
Q4
$458K Sell
2,475
-41,479
-94% -$7.69M 0.03% 707
2014
Q3
$7.29M Buy
43,954
+10,851
+33% +$1.78M 0.42% 67
2014
Q2
$5.17M Buy
+33,103
New +$5.23M 0.29% 112

Other funds holding ALXN